These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 3992151

  • 21. Distribution of resorption processes in the compacta and spongiosa of bones from lactating rats fed a low-calcium diet.
    Lozupone E, Favia A.
    Bone; 1988; 9(4):215-24. PubMed ID: 3166839
    [Abstract] [Full Text] [Related]

  • 22. Effect of long-term administration of porcine calcitonin in the development of dietary osteoporosis in cats.
    Jowsey J.
    Endocrinology; 1969 Dec; 85(6):1196-201. PubMed ID: 5347621
    [No Abstract] [Full Text] [Related]

  • 23. Partial maintenance of extra cancellous bone mass by antiresorptive agents after discontinuation of human parathyroid hormone (1-38) in right hindlimb immobilized rats.
    Ma Y, Jee WS, Chen Y, Gasser J, Ke HZ, Li XJ, Kimmel DB.
    J Bone Miner Res; 1995 Nov; 10(11):1726-34. PubMed ID: 8592950
    [Abstract] [Full Text] [Related]

  • 24. [Effect of imidazole on the trabecular bone volume of rats with calcium deficiency].
    Roudier R, Martin JL, Delbarre F.
    C R Seances Soc Biol Fil; 1984 Nov; 178(3):265-70. PubMed ID: 6238653
    [Abstract] [Full Text] [Related]

  • 25. Studies of bone tissue in rats treated by prednisolone and 1,25-(OH)2D3.
    Lindgren JU, Johnell O, DeLuca HF.
    Clin Orthop Relat Res; 1983 Dec; (181):264-8. PubMed ID: 6688979
    [Abstract] [Full Text] [Related]

  • 26. The effect on vertebral bone mass and strength of long term treatment with antiresorptive agents (estrogen and calcitonin), human parathyroid hormone-(1-38), and combination therapy, assessed in aged ovariectomized rats.
    Mosekilde L, Danielsen CC, Gasser J.
    Endocrinology; 1994 May; 134(5):2126-34. PubMed ID: 8156913
    [Abstract] [Full Text] [Related]

  • 27. Efficacy of calcitonin in the prevention of experimental osteoporosis.
    Carrozzo M, Pallante R, Cantatore FP, Lo Sasso F, Pipitone V.
    Panminerva Med; 1984 May; 26(4):267-72. PubMed ID: 6533551
    [No Abstract] [Full Text] [Related]

  • 28. Calcitonin treatment of immobilization osteoporosis in rats.
    Tuukkanen J, Jalovaara P, Väänänen K.
    Acta Physiol Scand; 1991 Jan; 141(1):119-24. PubMed ID: 2053438
    [Abstract] [Full Text] [Related]

  • 29. 1 Alpha-hydroxyvitamin D2 and 1 alpha-hydroxyvitamin D3 have anabolic effects on cortical bone, but induce intracortical remodeling at toxic doses in ovariectomized rats.
    Weber K, Kaschig C, Erben RG.
    Bone; 2004 Sep; 35(3):704-10. PubMed ID: 15336607
    [Abstract] [Full Text] [Related]

  • 30. Resorption is not essential for the stimulation of bone growth by hPTH-(1-34) in rats in vivo.
    Hock JM, Hummert JR, Boyce R, Fonseca J, Raisz LG.
    J Bone Miner Res; 1989 Jun; 4(3):449-58. PubMed ID: 2527459
    [Abstract] [Full Text] [Related]

  • 31. The pleiotropic effects of vitamin D in bone.
    Anderson PH, Lam NN, Turner AG, Davey RA, Kogawa M, Atkins GJ, Morris HA.
    J Steroid Biochem Mol Biol; 2013 Jul; 136():190-4. PubMed ID: 22981997
    [Abstract] [Full Text] [Related]

  • 32. The aged rat model of ovarian hormone deficiency bone loss.
    Kalu DN, Liu CC, Hardin RR, Hollis BW.
    Endocrinology; 1989 Jan; 124(1):7-16. PubMed ID: 2909382
    [Abstract] [Full Text] [Related]

  • 33. Skeletal effects of cyclic recombinant human growth hormone and salmon calcitonin in osteopenic postmenopausal women.
    Holloway L, Kohlmeier L, Kent K, Marcus R.
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1111-7. PubMed ID: 9100582
    [Abstract] [Full Text] [Related]

  • 34. New approaches to the problems of osteoporosis.
    Nordin BE, Need AG, Morris HA, Horowitz M.
    Clin Orthop Relat Res; 1985 Nov; (200):181-97. PubMed ID: 3905110
    [Abstract] [Full Text] [Related]

  • 35. [Calcitonin and bone aging].
    Reginster JY.
    Pathol Biol (Paris); 1997 Jan; 45(1):52-6. PubMed ID: 9097847
    [Abstract] [Full Text] [Related]

  • 36. Densitometric analysis in in vivo evaluation of synthetic salmon calcitonin activity.
    Gnudi S, Mongiorgi R, Moroni A, Bertocchi G.
    J Clin Pharm Ther; 1988 Apr; 13(2):125-30. PubMed ID: 3392126
    [Abstract] [Full Text] [Related]

  • 37. [Postmenopausal osteoporosis: are there alternatives to estrogen/gestagen substitution?].
    Gerber NJ, Rey B.
    Schweiz Rundsch Med Prax; 1991 Apr 16; 80(16):423-7. PubMed ID: 2038639
    [Abstract] [Full Text] [Related]

  • 38. Salmon calcitonin prevents cyclosporin-A-induced high turnover bone loss.
    Stein B, Takizawa M, Katz I, Joffe I, Berlin J, Fallon M, Epstein S.
    Endocrinology; 1991 Jul 16; 129(1):92-8. PubMed ID: 2055207
    [Abstract] [Full Text] [Related]

  • 39. [Effect of 1-alpha oxyvitamin D3 on bone tissue in systemic osteoporosis].
    Rodionova SS, Zatsepin ST, Shvets VN.
    Ortop Travmatol Protez; 1989 Feb 16; (2):37-40. PubMed ID: 2726218
    [Abstract] [Full Text] [Related]

  • 40. [Pharmacologic therapy of osteoporosis].
    Kushida K.
    Nihon Rinsho; 1994 Sep 16; 52(9):2367-77. PubMed ID: 7967083
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.